Module Four: Cancer Immunology Flashcards

(42 cards)

1
Q

What is the fundamental prediction hypothesis?

A

Immunodeficient individuals should display a dramatic incidence in tumour incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who published the paper which demonstrated no difference in cancer incidence between nude mice and normal mice?

A

Osias Stutman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transgenic animal studies reveal that tumour elimination requires

A

Interferon-gamma, perforin, TRAIL, Type 1 INF (INF alpha/beta)

And the following effector cells:
Innate immunity: NK cells, NKT cells, gamma/delta T cells
Adaptive Immunity: CD8 T cells (cytotoxic T Cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the three E’s of immunoediting?

A

Stage 1: elimination (immunosurveillance)
Stage 2: equilibrium
Stage 3: escape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is transformation?

A

The process of a cell becoming carcinogenic/malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does MIC activate?

A

NKG2D on NK cells

Release perforin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What causes the activation and maturation of dendritic cells?

A

The presence of tumour cells and tumour antigens initiates the release of danger cytokines such as INF alpha and heat shock proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CD8 T cells present antigen to what?

A

Class One MHC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the anecdotal evidence for immune reactivity to tumours in humans?

A
  • autopsy studies reveal that incidence of tumours may be much greater than incidence of cancer
  • spontaneous regression of established tumours have been reported
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the more direct evidence for immune reactivity to human tumours

A
  1. Immunosuppressed transplant recipients have increased incidence of non-viral cancers
  2. Cancer patients can develop spontanous adaptive and innate responses to their tumours
  3. The presence of tumour inflitrating lymphocytes is often a positive prognostic indicator of survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Evidence of equilibrium

A

Cancers that come back in transplant patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How to sustain equilibrium?

A
  1. Cellular dormancy
  2. Angiogenic dormancy
  3. Immune dormancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the tumour escape mechanisms?

A

Low immunogenicity
Antigen modulation
Immune suppression by tumour cells or regulatory T cells
Induction of lymphocyte apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do tumour cells induce apoptosis in T lymphocytes?

A

FAS activation

Cancer cells express FAS ligand and bind to FAS receptor on T lymphocytes leading to apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is immunotherapy? And who are the key players?

A

Treatment of disease by inducing, enhancing or suppressing the immune system.

Dendritic cells, B cells and T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do we induce an adaptive immune response?

A

Antigen
Effector cells (CD4 and CD8)
Antigen presenting cell
Immune target (pathogen/ tumour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do APCs present antigen?

A
Class one (endogenous I.e. Inside out)
Class Two (exogenous I.e. Outside in)
Dendritic cells
18
Q

What are the three signals for T cell activation?

A

Signal One: MHC:: TCR interaction
Signal Two: co-stimulation: CD80/86::CD28 interaction
Signal Three: competitive inhibition or co-stimulatory signals: CTLA-4 out competes CD28 for binding to CD80/86

19
Q

Types of cancer immunotherapy?

A

Adoptive cell transfer
Vaccination
Monoclonal antibodies
Immune modulators

20
Q

Examples of adoptive cell therapy

A

Lymphokine activated killer therapy

Tumour infiltrating lymphocytes therapy

21
Q

Genetic modifications of TILs

A

Increase TCR avidity to target
Chimeric Ag receptors
Transgenic approach (humanised mouse) - useful against colon cancer and melanoma

22
Q

Pros of TIL

A

ACT can eradicate tumours
GE modification to increase avidity/ specificity and helped identify best ACT cell populations
Potential for personalised medicine
May compliment other treatment modalities

23
Q

Cons of TIL therapy

A

Limited to patients that tolerate pretreatment conditioning
Most successful in melanoma - not applicable to all cancers
Not FDA approved
Expensive and laborious - requires specialised training and facilities

24
Q

Examples of anti cancer vaccines

A
Whole tumour cell vaccines
 Peptide vaccines
 Pathogen vector vaccines
 GM tumour cell vaccines 
DNA vaccines 
Fusion vaccines (tumour cells/ antigen + APC)
Prime boost vaccines
25
What was the first FDA approved therapeutic vaccine to treat cancer?
Spiuleucel T (Provence) For chemo refractory metastatic prostate cancer
26
What is a 223 AA protein that is expressed on activated lymphocytes?
CTLA-4
27
What are the function properties of CTLA-4?
In vitro X-linking with CTLA-4 inhibits T cell proliferation Blockade of CTLA4 with soluble intact Fab fragment promotes T cell proliferation soluble anti-CTLA-4 fab fragments enhance T cell responses to Peptide AG CTLA-4 KO mice exhibit severe T Cell proliferative disorders
28
What are the two FDA approved humanised anti-CLTA-4 monoclonal antibodies ?
Ipilimumab (IgG1) | Tremelimumab (IgG2)
29
Role of PD -1
Maintains peripheral tolerance and prevents autoimmunity
30
Issues with immunotherapy
Not all cancers respond as well as melanoma Side effects: colitis, skin and endocrine side effects Cost
31
What is a cold tumour?
Have very little inflammatory cells Enriched in immunosuppressive cytokines High numbers of Treg cells and MDSC
32
What are hot tumour cells
Enriched in Thelper 1 Chemokines | High number of effector immune cells high number of functional APCs
33
What do tumour specific CD8 T cells need to recognise on the surface of tumour cells before they will mount an attack?
Antigens
34
Why isn't recombinant interferon used much in cancer patients today?
It makes them too sick | And quality of life is diminished
35
How do you identify tumour specific antigens (neo-antigens)?
Next generation sequencing
36
How many nucleotides in the full human genome?
6 billion
37
What is the name of the component that codes for proteins
Exome
38
How many nucleotides code for protein?
1-2%
39
How many nucleotides code for an amino acid?
3
40
Which tumours are the most highly mutated and which have the lowest mutational burdens?
Lung cancer/ melanoma - most highly carcinogens Vs Childhood
41
What is the ATTAC cancer trial?
Antigen-targeted therapy against cancer
42
Steps of ATTAC cancer program
Cancer patient => tumour sampling and bio banking => gene sequencing => neo antigen prediction => advance T cell monitoring => next generation immunotherapy => systems biology => animal models => novel clinical trials